Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ae decrease » we decrease (Expand Search), _ decrease (Expand Search), a decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ae » i a (Expand Search), i e (Expand Search), i de (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ae decrease » we decrease (Expand Search), _ decrease (Expand Search), a decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ae » i a (Expand Search), i e (Expand Search), i de (Expand Search)
-
161
-
162
-
163
MMR mutants show decreased mating-type silencing.
Published 2020“…<i>sir1Δ</i> mutant was used as a positive control. <b>(D)</b> Cells of indicated strains were 10-fold serially diluted and then spotted onto SC (left), SD-Ura (middle) and SC+FOA(right) agar plates, the <i>sir1Δ</i> mutant served as a positive control. …”
-
164
Fold change with steady state myocardial mRNA levels for components of the inflammasome.
Published 2024Subjects: -
165
Solicited local AEs.
Published 2022“…Percentages reflect <i>n</i>/<i>N</i> where <i>n</i> is the number of participants with one or more AEs and <i>N</i> is the number of participants with available reactogenicity data after the given dose (solicited AEs) or the number of participants who received the given dose (unsolicited AEs). …”
-
166
-
167
-
168
-
169
TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment.
Published 2016“…</b> After 24 hours, RASAL1 was decreased; fold change 0.51+/-0.13 (P<0.05). <b>C.</b> Western blotting shows an apparent increase in TGFβ1 after 6 hours. …”
-
170
-
171
-
172
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8<sup>+</sup> T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8<sup>+</sup> T cells. …”
-
173
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8<sup>+</sup> T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8<sup>+</sup> T cells. …”
-
174
-
175
-
176
Triple stain for miR-200b, AE1/AE3, and laminin-5γ2 at the invasive front.
Published 2017“…<b>(B-F)</b> Enlarged area from A. <b>(B)</b> Tumor budding cells co-expressing cytokeratin AE1/AE3 and laminin-5γ2 (red) appear yellow as indicated by white arrowheads. …”
-
177
-
178
-
179
-
180